Search Results - "Lin, Ken Y"

Refine Results
  1. 1

    Ab Externo Imaging of Human Episcleral Vessels Using Fiberoptic Confocal Laser Endomicroscopy by Y Lin, Ken, Mosaed, Sameh

    Published in Journal of ophthalmic & vision research (01-07-2019)
    “…There is a growing interest in targeting minimally invasive surgery devices to the aqueous outflow system to optimize treatment outcomes. However, methods to…”
    Get full text
    Journal Article
  2. 2

    Seeing invisible light: 2-photon microperimetry to measure visual function by Mehta, Urmi, Palczewska, Grazyna, Lin, Ken Y., Browne, Andrew W.

    “…The accuracy of conventional visual function tests, which emit visible light, decreases in patients with corneal scars, cataracts, and vitreous hemorrhages. In…”
    Get full text
    Journal Article
  3. 3

    How Many Fenestrations Should I Make When Placing a Baerveldt Glaucoma Implant? A Laboratory Study by C Yang, Michael, D Yang, Christopher, Y Lin, Ken

    Published in Journal of ophthalmic & vision research (01-04-2023)
    “…This study investigates the effect of one versus two fenestrations on both fluid egress and opening pressure from a non-valved glaucoma implant. In this…”
    Get full text
    Journal Article
  4. 4

    Clinical Validation of a Handheld Deep Learning Tool for Identification of Glaucoma Medications by Yang, Christopher D, Wang, Jasmine, Verniani, Ludovico, Ghalehei, Melika, Chen, Lauren E, Lin, Ken Y

    Published in Journal of ophthalmic & vision research (01-04-2024)
    “…To validate a convolutional neural network (CNN)-based smartphone application for the identification of glaucoma eye drop medications in patients with normal…”
    Get full text
    Journal Article
  5. 5

    Durable partial response to pembrolizumab, lenvatinib, and letrozole in a case of recurrent uterine carcinosarcoma with ESR1 gene amplification by Soiffer, Jenny L., Fife, Alexander J., Gadad, Shrikanth S., Laurini, Javier A., Elvin, Julia A., Isani, Sara S., Lin, Ken Y.

    Published in Gynecologic oncology reports (01-08-2024)
    “…•ESR1 gene amplification occurs in 7% of uterine carcinosarcoma.•The presence of ESR1 gene amplification in recurrent uterine carcinosarcoma may be targeted by…”
    Get full text
    Journal Article
  6. 6

    The Incidence of Urgent Tube Shunt Surgery for Diabetic Neovascular Glaucoma at a Tertiary Academic Medical Center by LaRocca, Megan Corinne, Smith, Andrew K, Minckler, Don S, Lin, Ken Y

    “…Background: Diabetic neovascular glaucoma is a secondary glaucoma that may require immediate correction of elevated intraocular pressure to control pain and…”
    Get full text
    Journal Article
  7. 7

    Cervical Cancer by Lea, Jayanthi S., MD, Lin, Ken Y., MD, PhD

    “…Squamous cell cervical cancer incidence and mortality have been reduced dramatically as a result of successful screening in many countries. The incidence of…”
    Get full text
    Journal Article
  8. 8

    Activation of Akt as a Mechanism for Tumor Immune Evasion by Noh, Kyung Hee, Kang, Tae Heung, Kim, Jin Hee, Pai, Sara I, Lin, Ken Y, Hung, Chien-Fu, Wu, T-C, Kim, Tae Woo

    Published in Molecular therapy (01-03-2009)
    “…Immune evasion is an important reason why the immune system cannot control tumor growth. To elucidate the mechanism for tumor immune evasion, we generated an…”
    Get full text
    Journal Article
  9. 9

    Use of endoluminal vacuum therapy after anastomotic leak in a gynecologic oncology patient with rectosigmoid resection: A case report by Gowthaman, Divya, Gabor, Lisa R, Lin, Ken Y, Yang, Julie, Dellacerra, Gary A, Isani, Sara S, Kuo, Dennis Y

    Published in Gynecologic oncology reports (01-12-2022)
    “…•Anastomotic leak is an infrequent complication after colon resection and is associated with high morbidity and mortality.•Endoluminal vacuum therapy (EVAT)…”
    Get full text
    Journal Article
  10. 10

    Cervical Cancer Immunotherapy: Facts and Hopes by Ferrall, Louise, Lin, Ken Y, Roden, Richard B S, Hung, Chien-Fu, Wu, T-C

    Published in Clinical cancer research (15-09-2021)
    “…It is a sad fact that despite being almost completely preventable through human papillomavirus (HPV) vaccination and screening, cervical cancer remains the…”
    Get full text
    Journal Article
  11. 11

    PARP Inhibitors for Cancer Therapy by Lin, Ken Y., Kraus, W. Lee

    Published in Cell (06-04-2017)
    “…Rucaparib is an inhibitor of nuclear poly (ADP-ribose) polymerases (inhibition of PARP-1 > PARP-2 > PARP-3), following a similar drug, Olaparib. It disrupts…”
    Get full text
    Journal Article
  12. 12

    Ectopic expression of X-linked lymphocyte-regulated protein pM1 renders tumor cells resistant to antitumor immunity by Kang, Tae Heung, Noh, Kyung Hee, Kim, Jin Hee, Bae, Hyun Cheol, Lin, Ken Y, Monie, Archana, Pai, Sara I, Hung, Chien-Fu, Wu, T-C, Kim, Tae Woo

    Published in Cancer research (Chicago, Ill.) (15-04-2010)
    “…Tumor immune escape is a major obstacle in cancer immunotherapy, but the mechanisms involved remain poorly understood. We have previously developed an immune…”
    Get full text
    Journal Article
  13. 13

    Ultrasound‐assisted ocular drug delivery: A review of current evidence by Yang, Christopher D., Jessen, Jordan, Lin, Ken Y.

    Published in Journal of clinical ultrasound (01-06-2022)
    “…Efficient ocular drug delivery is a challenging clinical problem with various therapeutic options but no clearly preferred methodology. Given the ubiquity of…”
    Get full text
    Journal Article
  14. 14

    Combinatorial Treatment with PARP-1 Inhibitors and Cisplatin Attenuates Cervical Cancer Growth through Fos-Driven Changes in Gene Expression by Gupte, Rebecca, Lin, Ken Y, Nandu, Tulip, Lea, Jayanthi S, Kraus, W Lee

    Published in Molecular cancer research (05-08-2022)
    “…Cervical cancer continues to be a significant cause of cancer-related deaths in women. The most common treatment for cervical cancer involves the use of the…”
    Get full text
    Journal Article
  15. 15

    Long noncoding RNAs in cancer: From discovery to therapeutic targets by Choudhari, Ramesh, Sedano, Melina J, Harrison, Alana L, Subramani, Ramadevi, Lin, Ken Y, Ramos, Enrique I, Lakshmanaswamy, Rajkumar, Gadad, Shrikanth S

    Published in Advances in clinical chemistry (2020)
    “…Long noncoding RNAs (lncRNAs) have recently gained considerable attention as key players in biological regulation; however, the mechanisms by which lncRNAs…”
    Get full text
    Journal Article
  16. 16

    Drug-induced Acute Angle-closure Glaucoma: A Review by Yang, Michael C, Lin, Ken Y

    Published in Journal of current glaucoma practice (01-09-2019)
    “…Our goal is to review current literature regarding drug-induced acute angle-closure glaucoma (AACG) and provide ophthalmologists and general practitioners with…”
    Get full text
    Journal Article
  17. 17
  18. 18

    ADP-Ribosylation Levels and Patterns Correlate with Gene Expression and Clinical Outcomes in Ovarian Cancers by Conrad, Lesley B, Lin, Ken Y, Nandu, Tulip, Gibson, Bryan A, Lea, Jayanthi S, Kraus, W Lee

    Published in Molecular cancer therapeutics (01-01-2020)
    “…Inhibitors of nuclear PARP enzymes (e.g., PARP-1) have improved clinical outcomes in ovarian cancer, especially in patients with gene mutations or additional…”
    Get full text
    Journal Article
  19. 19

    Results of Trabectome Surgery Following Failed Glaucoma Tube Shunt Implantation: Cohort Study by Mosaed, Sameh, Chak, Garrick, Haider, Asghar, Lin, Ken Y., Minckler, Don S.

    Published in Medicine (Baltimore) (01-07-2015)
    “…To evaluate the safety and efficacy of Trabectome after failed tube shunt surgery.Twenty patients with prior failed tube shunt surgery who underwent Trabectome…”
    Get full text
    Journal Article
  20. 20

    Anterior Chamber Washout During Ahmed Valve Glaucoma Surgery Reduces the Incidence of Hypertensive Phase by Chang, Melissa M., Yang, Christopher D., Ly, Huy Q., Minckler, Donald S., Lin, Ken Y.

    Published in Journal of glaucoma (01-05-2023)
    “…Intraoperative anterior chamber (AC) washout reduces the odds of hypertensive phase (HP) by 95% compared with those not receiving washout during Ahmed glaucoma…”
    Get full text
    Journal Article